Movano (NASDAQ:MOVE – Get Free Report) is projected to release its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect the company to announce earnings of ($3.1664) per share and revenue of $6.71 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, August 18, 2026 at 9:30 AM ET.
Movano (NASDAQ:MOVE – Get Free Report) last posted its quarterly earnings data on Tuesday, May 19th. The technology company reported ($3.13) EPS for the quarter, missing analysts’ consensus estimates of ($2.65) by ($0.48). The firm had revenue of $0.51 million during the quarter, compared to analyst estimates of $7.62 million.
Movano Price Performance
NASDAQ MOVE opened at $12.16 on Thursday. The stock has a 50-day simple moving average of $17.25 and a 200 day simple moving average of $15.57. Movano has a twelve month low of $3.44 and a twelve month high of $26.72. The stock has a market capitalization of $336.10 million, a PE ratio of -0.89 and a beta of 0.88. The company has a debt-to-equity ratio of 4.28, a quick ratio of 2.04 and a current ratio of 2.14.
Institutional Inflows and Outflows
Analyst Ratings Changes
Separately, Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a research report on Sunday, May 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.
Read Our Latest Research Report on Movano
Key Movano News
Here are the key news stories impacting Movano this week:
- Positive Sentiment: An article reports that Corvex, Inc. signed a multiyear agreement to provide NVIDIA Blackwell GPU clusters and said the expansion would be funded without issuing additional equity. However, the report identifies Corvex—not Movano Inc.—as the company associated with the Nasdaq ticker MOVE, suggesting a possible ticker or company-mapping error. Corvex Signs Multi-Year Agreement to Provide NVIDIA Blackwell GPUs
- Neutral Sentiment: Broader U.S. markets initially extended their rally but reversed lower during Wednesday’s session, creating a less supportive backdrop for speculative technology and small-cap stocks. U.S. Stocks Move Back To The Downside After Initially Extending Recent Rally
- Negative Sentiment: Movano’s latest reported quarter showed a substantial revenue shortfall and a larger-than-expected loss, leaving investors focused on execution, cash needs and the company’s ability to generate meaningful commercial growth. This older financial weakness may continue to weigh on sentiment absent a new catalyst.
About Movano
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
See Also
- Five stocks we like better than Movano
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
